Chemotherapy-Induced Febrile Neutropenia Study
Author Information
Author(s): Okera M, Chan S, Dernede U, Larkin J, Popat S, Gilbert D, Jones L, Osuji N, Sykes H, Oakley C, Pickering L, Lofts F, Chowdhury S
Primary Institution: Guy's & St Thomas' NHS Foundation Trust
Hypothesis
What are the outcomes and management practices for chemotherapy-induced febrile neutropenia in the South West London Cancer Network?
Conclusion
The study highlights the need for improved clinical care pathways to manage chemotherapy-induced febrile neutropenia effectively.
Supporting Evidence
- 71 admissions for febrile neutropenia were reported involving 64 patients.
- 38 patients (59%) were female and 26 (41%) were male.
- 4 (6%) patients died during their admission to hospital for febrile neutropenia.
Takeaway
This study looked at patients who got sick from chemotherapy and found that we need to do better at helping them quickly.
Methodology
A prospective study capturing data on all cases of chemotherapy-induced febrile neutropenia over a 4-month period across seven hospitals.
Potential Biases
Potential selection bias and inconsistent reporting of toxicity data.
Limitations
The study could not capture patients who received chemotherapy at SWLCN hospitals but presented with febrile neutropenia at other hospitals.
Participant Demographics
The median age of participants was 60 years, with 59% female and 41% male.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website